Cargando…
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
The development of neutralizing antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following infection or vaccination is likely to be critical for the development of sufficient population immunity to drive cessation of the coronavirus disease of 2019 (COVID-19) pa...
Autores principales: | Luchsinger, Larry L., Ransegnola, Brett P., Jin, Daniel K., Muecksch, Frauke, Weisblum, Yiska, Bao, Weili, George, Parakkal Jovvian, Rodriguez, Marilis, Tricoche, Nancy, Schmidt, Fabian, Gao, Chengjie, Jawahar, Shabnam, Pal, Mouli, Schnall, Emily, Zhang, Huan, Strauss, Donna, Yazdanbakhsh, Karina, Hillyer, Christopher D., Bieniasz, Paul D., Hatziioannou, Theodora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685895/ https://www.ncbi.nlm.nih.gov/pubmed/32917729 http://dx.doi.org/10.1128/JCM.02005-20 |
Ejemplares similares
-
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020) -
Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis
por: Fujiuchi, Satoru, et al.
Publicado: (2016) -
Evaluation of Serological Tests for Detection of Antibodies against Lumpy Skin Disease Virus
por: Krešić, Nina, et al.
Publicado: (2020) -
Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil
por: da Silva Brito, Vanessa, et al.
Publicado: (2018) -
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
por: Pisanic, Nora, et al.
Publicado: (2020)